Men with PCa given GnRH antagonists with history of CVD event or indication had a 30% higher chance of developing any CVD, 63% higher chance of developing AMI and 74% higher chance of developing arrhythmia compared to men on GnRH agonists. Here, GNRH1 is linked to Arrhythmia.